Royalty Pharma
RPRX
#636
Rank
S$50.53 B
Marketcap
S$87.89
Share price
2.18%
Change (1 day)
75.06%
Change (1 year)

Market capitalization of Royalty Pharma (RPRX)

Market cap: S$50.53 Billion

As of November 2026 Royalty Pharma has a market cap of S$50.53 Billion. This makes Royalty Pharma the world's 636th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Royalty Pharma from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026S$50.53 B72.09%
2025S$29.36 B43.57%
2024S$20.45 B-8.05%
2023S$22.24 B-4.82%
2022S$23.36 B1%
2021S$23.13 B-9.96%
2020S$25.69 B

End of Day market cap according to different sources

On Nov 9th, 2026 the market cap of Royalty Pharma was reported to be:

S$50.41 Billion
by Nasdaq info icon info icon
S$50.53 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Abbott Laboratories
ABT
S$244.60 B 384.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$1.607 T 3,080.63%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
S$1.96 B-96.10%๐Ÿ‡บ๐Ÿ‡ธ USA